AVIR
Atea Pharmaceuticals (AVIR)
$19
About Atea Pharmaceuticals (AVIR)
Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.
Details
Daily high
$3.32
Daily low
$3.11
Price at open
$3.11
52 Week High
$4.60
52 Week Low
$2.75
Market cap
269.4M
Dividend yield
0.00%
Volume
1.2M
Avg. volume
509,496
P/E ratio
-1.54
Atea Pharmaceuticals News
Details
Daily high
$3.32
Daily low
$3.11
Price at open
$3.11
52 Week High
$4.60
52 Week Low
$2.75
Market cap
269.4M
Dividend yield
0.00%
Volume
1.2M
Avg. volume
509,496
P/E ratio
-1.54